Study of Aripiprazole in Patients With a History of Bipolar Disorder
1 other identifier
interventional
N/A
1 country
19
Brief Summary
The purpose of this study is to learn if aripiprazole is effective in the treatment of patients with a history of bipolar disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2000
Typical duration for phase_3
19 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2000
CompletedFirst Submitted
Initial submission to the registry
May 8, 2002
CompletedFirst Posted
Study publicly available on registry
May 10, 2002
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2003
CompletedNovember 11, 2013
September 1, 2007
3.3 years
May 8, 2002
November 7, 2013
Conditions
Keywords
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (19)
Local Institution
Birmingham, Alabama, United States
Local Institution
Tuscaloosa, Alabama, United States
Local Institution
Chillicothe, California, United States
Local Institution
Riverside, California, United States
Local Institution
Stanford, California, United States
Local Institution
Torrance, California, United States
Local Institution
Atlanta, Georgia, United States
Local Institution
Chicago, Illinois, United States
Local Institution
Louisville, Kentucky, United States
Local Institution
Shreveport, Louisiana, United States
Local Institution
Belmont, Massachusetts, United States
Local Institution
Las Vegas, Nevada, United States
Local Institution
Albuquerque, New Mexico, United States
Local Institution
New York, New York, United States
Local Institution
Philadelphia, Pennsylvania, United States
Local Institution
Memphis, Tennessee, United States
Local Institution
Nashville, Tennessee, United States
Local Institution
Austin, Texas, United States
Local Institution
San Antonio, Texas, United States
Related Publications (3)
Kemp DE, Calabrese JR, Tran QV, Pikalov A, Eudicone JM, Baker RA. Metabolic syndrome in patients enrolled in a clinical trial of aripiprazole in the maintenance treatment of bipolar I disorder: a post hoc analysis of a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2010 Sep;71(9):1138-44. doi: 10.4088/JCP.09m05159gre. Epub 2010 May 4.
PMID: 20492838DERIVEDMuzina DJ, Momah C, Eudicone JM, Pikalov A, McQuade RD, Marcus RN, Sanchez R, Carlson BX. Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study. Int J Clin Pract. 2008 May;62(5):679-87. doi: 10.1111/j.1742-1241.2008.01735.x. Epub 2008 Mar 25.
PMID: 18373615DERIVEDKeck PE Jr, Calabrese JR, McIntyre RS, McQuade RD, Carson WH, Eudicone JM, Carlson BX, Marcus RN, Sanchez R; Aripiprazole Study Group. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. J Clin Psychiatry. 2007 Oct;68(10):1480-91. doi: 10.4088/jcp.v68n1003.
PMID: 17960961DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Purpose
- TREATMENT
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
May 8, 2002
First Posted
May 10, 2002
Study Start
March 1, 2000
Primary Completion
June 1, 2003
Study Completion
June 1, 2003
Last Updated
November 11, 2013
Record last verified: 2007-09